Wasn't it Dr Moschovis that was supposed to be overseeing the whole study (in Dr Currie's position?)? If that is the case, then I don't think I would want his involvement in the restarted study, but having MGH on board is important....bit of a quandary.
RAP Price at posting:
6.6¢ Sentiment: Buy Disclosure: Held